Acute Decompensated Heart Failure
Acute Decompensated Heart Failure - Related Videos
07:35
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
0 Views •
Cited by 21 •
2011
A method of gene transfer for the treatment of ischemic heart failure is described using a swine model of myocardial infarction. Our simple and reproducible method enables us to readily evaluate the efficacy of various gene transfers with a very simple and reproducible way.
01:29
Heart Failure II: Pathophysiology
0 Views •
2025
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:21
Acute Respiratory Failure-I
0 Views •
2024
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function. Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
01:21
Acute Respiratory Failure-II
0 Views •
2024
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood. The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: • Ventilation-Perfusion (V/Q) Mismatch: The...
01:29
Acute Respiratory Failure-V
0 Views •
2024
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment. Ensure that patients are monitored continuously for their response to therapy, including changes in...
FAQs
The congestion-perfusion profile helps clinicians distinguish whether elevated pressures and fluid accumulation are the dominant problems or whether tissue perfusion is also inadequate. This distinction matters because it links bedside findings to the urgency and type of support required, including decongestion or measures aimed at maintaining perfusion.
Sympathetic and renin-angiotensin-aldosterone activation can increase vasoconstriction, sodium retention, and fluid accumulation. These responses raise cardiac workload and intensify pressure and volume stress on an already impaired heart. Recognizing this mechanism explains why uncontrolled compensation can amplify congestion rather than restore effective circulation.
Impaired pumping or filling can raise intracardiac pressures, but the resulting clinical pattern may include pulmonary congestion, systemic congestion, inadequate tissue perfusion, or a combination of these findings. Identifying which consequences are present helps clinicians characterize severity and select supportive or decongestive measures appropriate to the patient’s current condition.
The initial assessment needs to establish the extent of congestion and whether tissue perfusion is inadequate, while recognizing that severe presentations may require urgent support. This clinical profile provides the basis for deciding whether oxygen or ventilatory support is needed and which therapies should be prioritized during early management.
Treatment is matched to the patient’s observed physiology. Oxygen or ventilatory support may be provided when needed, while intravenous diuretics address fluid accumulation. Vasodilators can be selected as part of the treatment approach, and inotropes may be considered when inadequate tissue perfusion is a major concern. These options support different clinical priorities rather than serving as interchangeable treatments.
Management should address both the immediate hemodynamic problem and the factors that triggered deterioration. Treating precipitating factors can help prevent continued worsening while therapies reduce congestion or support perfusion. Timely, coordinated care is intended to limit organ injury, reduce hospitalization, and improve outcomes, including lowering mortality risk.